This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Agilent Acquires ULTRA Scientific Assets, Expands Portfolio
by Zacks Equity Research
Agilent (A) recently completes the buyout of the business assets of ULTRA Scientific, thereby expanding its already vast product portfolio.
Agilent (A) to Acquire ProZyme, Expand Glycan Market Share
by Zacks Equity Research
Agilent (A) agrees to acquire glycan analysis company ProZyme for an undisclosed amount.
Agilent (A) Opens Logistics Center, Expands China Foothold
by Zacks Equity Research
Agilent (A) opens a new logistics center in Shanghai to ensure timely delivery of its services in the country.
Agilent Technologies (A) Down 4.5% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Agilent Technologies (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Agilent (A) Down 2.6% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Agilent's AATI Acquisition to Strengthen Portfolio, Footprint
by Zacks Equity Research
Agilent (A) is set to acquire AATI, a developer of automated nucleic acid analysis systems using capillary electrophoresis methods, for $250 million.
Agilent (A) Q1 Earnings & Revenues Beat, '18 View Positive
by Zacks Equity Research
Agilent (A) first-quarter fiscal 2018 results benefit from robust top-line growth and improving end-market demand.
Is a Surprise Coming for Agilent Technologies (A) This Earnings Season?
by Zacks Equity Research
Agilent Technologies (A) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Agilent (A) Down 3.7% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Agilent (A) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Itron Extends SMECO Contract, Offers Outsourced Solution
by Zacks Equity Research
Itron's (ITRI) contract extension with SMECO anticipated to drive bookings growth in the near term.
Itron (ITRI) Q3 Earnings & Revenues Lag on Shipment Delays
by Zacks Equity Research
Itron's (ITRI) top and bottom lines missed the Zacks Consensus Estimate in Q3 on shipment delays. The company updated its full-year 2017 guidance.
Teradyne (TER) in Focus: Stock Moves 7.4% Higher
by Zacks Equity Research
Teradyne (TER) was a big mover last session, as the company saw its shares rise more than 7% on the day.
Will Agilent Technologies (A) Crush Estimates at Its Next Earnings Report?
by Zacks Equity Research
Agilent Technologies (A) has seen a nice short-term history of beating earnings estimates, and looks poised to crush analyst expectations in its next earnings report as well.
Agilent Technologies (A) Up 10.6% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Agilent Technologies (A) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
How Agilent Technologies (A) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Agilent Technologies (A) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
Is Agilent Technologies (A) Stock a Solid Choice Right Now?
by Zacks Equity Research
Agilent Technologies (A) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.
Why Agilent Technologies (A) Stock Might be a Great Pick
by Zacks Equity Research
Agilent Technologies (A) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Agilent (A) Up 4.8% Since Earnings Report: Can It Continue?
by Zacks Equity Research
A reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Agilent (A) and Transcriptic Partner on Biology Automation
by Zacks Equity Research
Agilent Technologies, Inc. (A) has significantly expanded its product portfolio with its focus on continued innovation and collaborations with growing companies.